Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 4
1959 8
1960 19
1961 26
1962 40
1963 81
1964 89
1965 96
1966 70
1967 85
1968 78
1969 97
1970 83
1971 102
1972 116
1973 113
1974 107
1975 89
1976 134
1977 121
1978 106
1979 130
1980 120
1981 139
1982 124
1983 135
1984 142
1985 133
1986 130
1987 99
1988 110
1989 115
1990 93
1991 97
1992 89
1993 78
1994 78
1995 103
1996 83
1997 98
1998 108
1999 100
2000 120
2001 96
2002 126
2003 156
2004 215
2005 315
2006 411
2007 346
2008 368
2009 360
2010 304
2011 341
2012 299
2013 301
2014 286
2015 297
2016 282
2017 283
2018 290
2019 318
2020 357
2021 353
2022 355
2023 336
2024 114

Text availability

Article attribute

Article type

Publication date

Search Results

10,195 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for acetonide
Search for cetonid instead (3 results)
Enigma of Intramuscular Triamcinolone Acetonide (Kenalog()) Efficacy.
Shahinfar S, Maibach H. Shahinfar S, et al. Clin Pharmacokinet. 2023 Sep;62(9):1189-1199. doi: 10.1007/s40262-023-01297-5. Epub 2023 Aug 19. Clin Pharmacokinet. 2023. PMID: 37598107 Review.
Triamcinolone acetonide is a glucocorticosteroid used in standard clinical practice for its anti-inflammatory properties. ...We summarize the existing literature on the pharmacokinetic and pharmacodynamic mechanisms of intramuscular triamcinolone acetonide (Kenalog( …
Triamcinolone acetonide is a glucocorticosteroid used in standard clinical practice for its anti-inflammatory properties. ...We summa …
Suprachoroidal Space Triamcinolone Acetonide: A Review in Uveitic Macular Edema.
Fung S, Syed YY. Fung S, et al. Drugs. 2022 Sep;82(13):1403-1410. doi: 10.1007/s40265-022-01763-7. Epub 2022 Aug 26. Drugs. 2022. PMID: 36018461 Free PMC article. Review.
Triamcinolone acetonide injectable suspension for suprachoroidal use (Xipere(); SCS triamcinolone acetonide) is a corticosteroid approved in the USA for the treatment of macular edema associated with uveitis. ...Recently, a triamcinolone acetonide suspension …
Triamcinolone acetonide injectable suspension for suprachoroidal use (Xipere(); SCS triamcinolone acetonide) is a corticostero …
Triamcinolone Acetonide Extended-Release: A Review in Osteoarthritis Pain of the Knee.
Paik J, Duggan ST, Keam SJ. Paik J, et al. Drugs. 2019 Mar;79(4):455-462. doi: 10.1007/s40265-019-01083-3. Drugs. 2019. PMID: 30847805 Free PMC article. Review.
Triamcinolone acetonide ER was generally well tolerated, with a tolerability profile similar to that of triamcinolone acetonide CS and placebo. ...Thus, triamcinolone acetonide ER expands the treatment options available for the management of OA pain of the kn …
Triamcinolone acetonide ER was generally well tolerated, with a tolerability profile similar to that of triamcinolone acetonide …
Fluocinolone acetonide for the treatment of diabetic macular edema.
Veritti D, Sarao V, Diplotti L, Samassa F, Lanzetta P. Veritti D, et al. Expert Opin Pharmacother. 2017 Oct;18(14):1507-1516. doi: 10.1080/14656566.2017.1363182. Epub 2017 Aug 9. Expert Opin Pharmacother. 2017. PMID: 28764565 Review.
Fluocinolone acetonide intravitreal implant is a non-erodible implant approved for the treatment of diabetic macular edema (DME) insufficiently responsive to available therapies. Areas covered: The injectable intravitreal implant releases fluocinolone acetonide at a …
Fluocinolone acetonide intravitreal implant is a non-erodible implant approved for the treatment of diabetic macular edema (DME) insu …
Triamcinolone acetonide in ocular therapeutics.
Jermak CM, Dellacroce JT, Heffez J, Peyman GA. Jermak CM, et al. Surv Ophthalmol. 2007 Sep-Oct;52(5):503-22. doi: 10.1016/j.survophthal.2007.06.004. Surv Ophthalmol. 2007. PMID: 17719372 Review.
Triamcinolone acetonide has been effectively used in ocular therapeutics for over 50 years. ...This comprehensive review discusses the pharmacokinetics of triamcinolone acetonide and summarizes its uses in a number of diseases, both intraocular and extraocular. ...
Triamcinolone acetonide has been effectively used in ocular therapeutics for over 50 years. ...This comprehensive review discusses th …
Triamcinolone acetonide. A review of its pharmacological properties and therapeutic efficacy in the management of allergic rhinitis.
Jeal W, Faulds D. Jeal W, et al. Drugs. 1997 Feb;53(2):257-80. doi: 10.2165/00003495-199753020-00006. Drugs. 1997. PMID: 9028745 Review.
Once symptoms are under control, the dosage of aqueous triamcinolone acetonide may be reduced from 220 to 110 micrograms/day without loss of effect. ...The use of intranasal triamcinolone acetonide and oral loratadine in combination did not confer any additional adv …
Once symptoms are under control, the dosage of aqueous triamcinolone acetonide may be reduced from 220 to 110 micrograms/day without …
Fluocinolone acetonide intravitreal implant (Iluvien): in diabetic macular oedema.
Sanford M. Sanford M. Drugs. 2013 Feb;73(2):187-93. doi: 10.1007/s40265-013-0010-x. Drugs. 2013. PMID: 23335133 Review.
Fluocinolone acetonide intravitreal implant (Iluvien) is an injectable, non-erodible, corticosteroid implant that is approved in several European countries for the treatment of chronic diabetic macular oedema (DMO). ...Fluocinolone acetonide intravitreal implant rec …
Fluocinolone acetonide intravitreal implant (Iluvien) is an injectable, non-erodible, corticosteroid implant that is approved in seve …
Management of spasticity in progressive multiple sclerosis: efficacy of repeated intrathecal triamcinolone acetonide administration.
Abu-Mugheisib M, Benecke R, Zettl UK. Abu-Mugheisib M, et al. Curr Pharm Des. 2012;18(29):4564-9. doi: 10.2174/138161212802502251. Curr Pharm Des. 2012. PMID: 22612755 Review.
Different effective treatment schemes have been established. Nevertheless the value of intrathecal triamcinolone acetonid (TCA) in MS is still a controversial issue. Bearing in mind that only limited data are available and due to its invasive application form repeated TCA …
Different effective treatment schemes have been established. Nevertheless the value of intrathecal triamcinolone acetonid (TCA) in MS …
Effects of triamcinolone acetonide injections with and without preservative.
Jonas JB. Jonas JB. Br J Ophthalmol. 2007 Sep;91(9):1099-101. doi: 10.1136/bjo.2007.117432. Br J Ophthalmol. 2007. PMID: 17709575 Free PMC article.
Using triamcinolone acetonide without preservative may improve safety...
Using triamcinolone acetonide without preservative may improve safety...
10,195 results
You have reached the last available page of results. Please see the User Guide for more information.